A study headed by researchers at the Applied Biomedical Science Institute and collaborators have uncovered a region of the SARS-CoV-2 virus spike protein that induces potentially pathogenic ...

Our verdict There is some evidence that the spike proteins generated by the Moderna Covid-19 vaccine leave the site of injection. There is also evidence that the spike protein on the actual virus can ...

New research has uncovered a series of mutations in the SARS-CoV-2 spike protein that enhanced the virus' ability to infect the brains of mice. The findings may help scientists understand its ...

Scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.

Early in the pandemic, most research, including our own, focused on designing drugs that could block the virus's spike protein. This was a logical first step, but as we've seen, the virus is a ...

The spike protein has two main parts: the S1 domain, which varies greatly among different strains of the virus, and the S2 domain, which is highly conserved across different coronaviruses.

This means the antibodies can maintain their hold on the spike protein long enough to neutralize the virus in the body.

In their latest research, the scientists used EVE-Vax to design 83 brand-new versions of the "spike" protein on SARS-CoV-2, which is the main surface protein the virus uses to infect human cells.

A mutation on the spike protein of the virus that causes COVID-19 could help it infect the brain by forcing it to use a cellular "back door." ...

Viruses with a deletion in the spike protein are better able to infect the brains of mice ‘These findings suggest there might be treatments that could work better to clear the virus from the ...